JNJ:TSX, Johnson & Johnson CDR (CAD Hedged)

JNJ stock overview

Johnson & Johnson CDR (CAD Hedged) (JNJ:TSX) closed at $34.42 on November 20, 2026, up 1.35% on the day. The stock trades 6.6% below its 52-week high of $36.87 and 31.5% above its 52-week low of $26.17. Over the past year, it gained 28.9%. Johnson & Johnson CDR (CAD Hedged) is part of the Health Care sector.

Key figures

Price
$34.42
Day change
+1.35%
Volume
21,440
Average volume
16,212
Market cap
852B+
52-week range
$26.17 – $36.87
50-day average
$34.10
200-day average
$32.13

Price action over the past year

In 229 trading sessions since December 23, 2025, JNJ closed higher on 118 days (52%). Its best day was November 4, 2026 (+4.13%) and its worst was October 13, 2026 (-4.74%). It never moved 10% or more in a single session.

Recent signals

JNJ news

About Johnson & Johnson CDR (CAD Hedged)

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity.

Similar stocks

Find more stocks like JNJ with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.